激活FOXO3诱导的细胞循环停止,调节铁化
Huanjie Huang1,2, Matthias van Sligtenhorst1,2,3, Alida M M Smits1,2
1Oncode Institute, University Medical Center Utrecht, Utrecht, The Netherlands.
Cell death discovery
|October 16, 2025
概括
FOXO3激活保护细胞免受铁,一种依赖铁的细胞死亡. 这种转录因子通过细胞循环停止,降低过氧化水平和减少铁的吸收来减少铁.
科学领域:
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 福克索转录因子调节细胞对压力的反应.
- 通过酸化和核排斥,PKB/AKT信号抑制FOXO活动.
- 众所周知,FOXO蛋白通过减轻压力来预防细胞死亡.
研究的目的:
- 研究FOXO3激活在保护细胞免受ferroptosis中的作用.
- 阐明FOXO3赋予耐铁亡的机制.
主要方法:
- 使用了未经转化的hTERT-RPE-1细胞.
- 通过FOXO3激活来评估铁亡的抑制.
- 分析了FOXO3介导的细胞周期变化,活性氧物种,铁含量和特定蛋白质表达 (p27,TFR1,ACSL4,PEX5).
主要成果:
- 通过FOXO3激活保护细胞免受铁亡.
- 保护涉及p27诱导的G1细胞周期停止.
- FOXO3降低了细胞中的H2O2水平,限制了芬顿反应基质.
- 通过减少TFR1表达,FOXO3降低了细胞铁的含量.
- FOXO3降低了ACSL4和PEX5的表达,它们是铁亡的关键参与者.
结论:
- FOXO3激活提供了对铁亡的多层保护.
- FOXO3 影响细胞循环,氧化还原平衡,铁代谢和脂质代谢,以防止铁灭.
- FOXO3激活代表了一种新的细胞防护程序,可以防止铁亡.
相关概念视频
Necrosis
6.3K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.3K
Negative Regulator Molecules
38.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.2K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
DNA Damage can Stall the Cell Cycle
10.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.0K

